Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Hypercalcemia of Malignancy|Metastatic Cancer|Musculoskeletal Complications|Pain
Interventions: DRUG: zoledronic acid|PROCEDURE: quality-of-life assessment
Sponsor: University of Leeds
Collaborators: University of Sheffield